Jose Banchs Selected Research

C-Reactive Protein

9/2015	Longitudinal Changes in Multiple Biomarkers Are Associated with Cardiotoxicity in Breast Cancer Patients Treated with Doxorubicin, Taxanes, and Trastuzumab.
3/2014	Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jose Banchs Research Topics

Disease

22	Neoplasms (Cancer) 01/2023 - 04/2011
13	Cardiotoxicity 11/2023 - 09/2012
8	Breast Neoplasms (Breast Cancer) 01/2023 - 09/2012
5	Heart Failure 01/2023 - 09/2012
5	Left Ventricular Dysfunction 01/2023 - 06/2014
4	Heart Diseases (Heart Disease) 10/2020 - 04/2011
3	Cardiovascular Diseases (Cardiovascular Disease) 11/2023 - 10/2018
3	Sarcoma (Soft Tissue Sarcoma) 11/2023 - 01/2017
3	Coronary Artery Disease (Coronary Atherosclerosis) 11/2021 - 04/2011
3	Dyspnea (Shortness of Breath) 01/2021 - 05/2016
3	Cardiomyopathies (Cardiomyopathy) 10/2018 - 04/2011
2	Pericardial Effusion 01/2019 - 12/2017
2	Hemorrhage 12/2017 - 05/2016
2	Chest Pain (Chest Pains) 07/2015 - 05/2015
2	Lung Neoplasms (Lung Cancer) 04/2015 - 01/2012
1	Aortic Dissection 08/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Cytokine Release Syndrome 01/2022
1	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2021
1	Edema (Dropsy) 12/2021
1	Capillary Leak Syndrome 12/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 11/2021
1	Thrombophilia 01/2021
1	Hodgkin Disease (Hodgkin's Disease) 10/2020
1	Esophageal Neoplasms (Esophageal Cancer) 10/2020
1	Osteosarcoma (Osteogenic Sarcoma) 01/2019
1	Thrombocytopenia (Thrombopenia) 01/2019
1	Multiple Myeloma 10/2018
1	Thrombosis (Thrombus) 10/2018
1	Hypertension (High Blood Pressure) 10/2018
1	Vascular Diseases (Vascular Disease) 01/2018
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2018
1	Carcinoid Tumor (Carcinoid) 10/2017
1	Carcinoid Heart Disease 10/2017
1	Hypoxia (Hypoxemia) 05/2016
1	Embolism (Embolus) 05/2016
1	Heart Arrest (Cardiac Arrest) 05/2016
1	Hypotension (Low Blood Pressure) 05/2016
1	Pulmonary Embolism 05/2016
1	Myocardial Infarction 07/2015
1	Takotsubo Cardiomyopathy 07/2015
1	Lymphoma (Lymphomas) 05/2015
1	Aneurysm (Aneurysms) 05/2015

Drug/Important Bio-Agent (IBA)

7	Trastuzumab (Herceptin)FDA Link 01/2023 - 09/2012
5	Biomarkers (Surrogate Marker)IBA 11/2023 - 09/2012
5	AnthracyclinesIBA 01/2023 - 09/2012
5	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2021 - 03/2014
4	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2017 - 09/2012
3	Troponin IIBA 09/2015 - 09/2012
3	Taxoids (Taxanes)IBA 09/2015 - 09/2012
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2021 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 02/2014
2	Proteasome InhibitorsIBA 10/2018 - 01/2018
2	TroponinIBA 01/2017 - 05/2015
2	C-Reactive ProteinIBA 09/2015 - 03/2014
2	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 09/2015 - 03/2014
2	pro-brain natriuretic peptide (1-76)IBA 09/2015 - 03/2014
2	Peroxidase (Myeloperoxidase)IBA 09/2015 - 03/2014
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2015 - 03/2014
1	Tyrosine Kinase InhibitorsIBA 08/2023
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2023
1	omega-Chloroacetophenone (Mace)IBA 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	tocilizumab (atlizumab)FDA Link 01/2022
1	tagraxofuspIBA 12/2021
1	NAD (NADH)IBA 11/2021
1	Adenosine Triphosphate (ATP)IBA 11/2021
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 11/2021
1	antineoplaston A10 (A 10)IBA 01/2021
1	mesoglycanIBA 01/2021
1	Dexrazoxane (Zinecard)FDA LinkGeneric 01/2020
1	Troponin T (Troponin T1)IBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Trinitrotoluene (TNT)IBA 01/2020
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 12/2019
1	NivolumabIBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	carfilzomibIBA 10/2018
1	Angiogenesis InhibitorsIBA 01/2018
1	Alkylating AgentsIBA 01/2018
1	Aromatase InhibitorsIBA 01/2018
1	Tamoxifen FDA LinkGeneric 01/2018
1	AntimetabolitesIBA 01/2018
1	AnticoagulantsIBA 12/2017
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 10/2017
1	Galectin 3 (LGALS3)IBA 09/2015
1	Growth Differentiation Factor 15IBA 09/2015
1	EnzymesIBA 07/2015

Therapy/Procedure

21	Therapeutics 11/2023 - 04/2011
7	Drug Therapy (Chemotherapy) 01/2023 - 04/2011
3	Radiotherapy 10/2020 - 01/2012
1	Cell Transplantation 12/2021
1	Indwelling Catheters (Indwelling Catheter) 01/2021
1	Proton Therapy 10/2020
1	Contraindications 01/2019
1	Resuscitation 05/2016
1	Colectomy 05/2016
1	Thrombolytic Therapy 05/2016
1	Cardiopulmonary Resuscitation (CPR) 05/2016